Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

7.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

4.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same author

Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson's disease-relevant LRRK2-G2019S mutation.

iScience·2026
Same author

Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis.

Frontiers in immunology·2026
Same author

Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS.

Journal of neuroinflammation·2026
Same author

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Neurological research and practice·2026
Same author

Diagnosis-independent contribution of low-grade inflammation to cortical atrophy across psychiatric disorders.

Brain, behavior, and immunity·2026

Related Experiment Video

Updated: Mar 5, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K

Activation of FXR pathway does not alter glial cell function.

Stefanie Albrecht1, Ann-Katrin Fleck2, Ina Kirchberg1

  • 1Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany.

Journal of Neuroinflammation
|March 30, 2017
PubMed
Summary

Farnesoid-X-receptor (FXR) is not essential for oligodendrocyte differentiation in the central nervous system. FXR agonists may treat multiple sclerosis by targeting peripheral immune cells, not brain cells.

Keywords:
AstrocytesFXRGW4064MicrogliaNuclear receptorsOligodendrocytes

More Related Videos

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
09:21

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor

Published on: January 4, 2016

10.5K
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

13.2K

Related Experiment Videos

Last Updated: Mar 5, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K
Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
09:21

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor

Published on: January 4, 2016

10.5K
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

13.2K

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Farnesoid-X-receptor (FXR) is expressed in immune cells and shows protective effects in inflammation models like experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS).
  • FXR agonists are being investigated for metabolic diseases and show promise for inflammatory-demyelinating CNS diseases like MS.
  • Oligodendrocyte dysfunction and impaired remyelination are key features of MS, with differentiation blocks in oligodendroglial progenitor cells.

Purpose of the Study:

  • To investigate the functional role of FXR in glial cells, particularly in oligodendroglial differentiation.
  • To determine if FXR deficiency or activation impacts oligodendroglial differentiation and remyelination.
  • To assess the effect of FXR activation on pro-inflammatory responses in astrocytes and microglia and their subsequent impact on oligodendroglial differentiation.

Main Methods:

  • Primary murine oligodendrocytes were isolated from FXR-deficient (FXR Ko) and wild-type (WT) mice.
  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunocytochemistry were used to analyze oligodendrocyte markers.
  • In vitro and ex vivo models were employed, alongside histological analyses of oligodendrocytes in FXR Ko mice.

Main Results:

  • FXR is expressed in both oligodendroglial progenitor cells (OPCs) and mature oligodendrocytes (OLs).
  • FXR deficiency did not impair oligodendroglial differentiation in vitro or in vivo.
  • Activation of FXR with GW4064 did not affect oligodendroglial differentiation, remyelination, or the expression of pro-inflammatory molecules in astrocytes or microglia.

Conclusions:

  • FXR is dispensable for oligodendroglial differentiation.
  • FXR agonists like GW4064 may be a therapeutic strategy for MS by targeting peripheral immune cells, not central nervous system-resident cells.
  • The study suggests FXR's therapeutic potential in MS lies in modulating peripheral inflammation rather than directly affecting oligodendrocytes or other glial cells.